Ceritinib - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by BeiGene; Helsinn Therapeutics
- Drug Class Antineoplastics; Diamines; Piperidines; Pyrimidines; Small molecules; Sulfones
- Mechanism of Action Anaplastic lymphoma kinase inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 58
- NDAs 2
- International Patents 386
- Patent Applications 761
Table of Contents

Disclaimer